Bright Uro

Aliso Viejo, United States Founded: 2021 • Age: 5 yrs
Diagnostic devices for lower urinary tract diseases are developed.

About Bright Uro

Bright Uro is a Healthcare company based in Aliso Viejo (United States) founded in 2021 by Derek Herrera. Diagnostic devices for lower urinary tract diseases are developed. Bright Uro has raised $94.99 million across 8 funding rounds from investors including NIH, Laborie Medical and HHS. The company has 23 employees. Its chief executive, as recorded, is Derek Herrera. Its focus areas include Life Sciences, Genitourinary Disorders, In Vitro Diagnostic Tests and Urology. Its legal entity is BRIGHT URO, INC. Its competitors include Stream DX, Clariflow and Spark Diagnostics; 1 of its 3 listed competitors has raised funding.

Company details

Bright Uro was founded in 2021 and is headquartered in Aliso Viejo, United States. Operations center on the medical device sector, specifically urology diagnostics. The Glean Urodynamics System is offered, which includes an insertion tool, a Bluetooth-enabled pressure sensor within a flexible silicone tube, a software application, and a uroflowmeter for measuring volume and flow rates. Focus remains on tools for lower urinary tract disease assessment.

  • Headquarters Aliso Viejo, United States
  • Employees 23
  • Founders Derek Herrera
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website brighturo.com
  • Legal Name Bright Uro, Inc.
Operational Areas
Key Metrics
  • Total Equity Funding
    $94.99M (USD)

    in 8 rounds

  • Latest Funding Round
    $15M (USD), Series A

    Jun 2025

  • Investors
    NIH

    & 8 more

  • Employee Count
    23

Funding Insights of Bright Uro

Bright Uro has successfully raised a total of $94.99M across 8 strategic funding rounds. The most recent funding activity was a Series A round of $15 million completed in June 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $94.99M
  • Total Rounds 8
  • Last Round Series A β€” $15M
  • First Round $2.05M

    (Sep 2021)

  • Investors Count 9

All 8 funding rounds of Bright Uro with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2025$15MSeries A––
–
Jun 2025$14.7MSeries A––
–
Jan 2025$1.75MGrant––
Oct 2024$32MSeries A–Laborie Medical
Nov 2023$29.29MSeries A–Laborie Medical
–
Sep 2022$2MGrant––
Jun 2022$4MSeed–Academy Investor Network
Sep 2021$2.05MGrant––
Valuation history

9 investors in total: 8 institutional and 1 angel.

Investors in Bright Uro

Bright Uro has secured backing from 9 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include NIH, Laborie Medical and HHS.

All
Venture Fund
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
freepointcg.com
academyinvestor.com
Administers health care and support for military personnel and operations.
health.milFalls Church, United States
Medical products for female lower urinary tract dysfunctions are provided.
1967laborie.comMississauga, Canada
Multiple courses and degrees across diversified streams are offered.
1987ucop.eduOakland, United States
Drug discovery services are provided to the biopharma sector.
1887nih.govUnited States
Public health and human services are overseen by HHS.
1953hhs.gov

Fred Moll

Indian angel investor with focus on early-stage tech startups.
unknown_caa959cdc5294ad5b
Premium access

Investor details for Bright Uro

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Bright Uro

7 people are tracked at Bright Uro (5 in leadership, 2 in team); the tracked headcount is 23.

NameRoleGroup
Derek Herrera
Founder & CEOLeadership
Bryan Nowroozi
Chief Scientific OfficerLeadership
Brittany U. Carter, DHSc, MPH
Senior Director Of Clinical AffairsLeadership
Kevin Hershberger
Chief Financial OfficerLeadership
Tim Kelp
Sales DirectorLeadership
Katelyn Shirlow Ms
Clinical SpecialistTeam
Elinor Banai
Grants ManagerTeam
Premium access

Complete people profiles for Bright Uro

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Bright Uro

3 dated milestones of Bright Uro across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Bright Uro is founded.
  2. Funding First funding round of $2.1M.
  3. Funding Latest funding round, Series A, of $15.0M.

Competitors of Bright Uro

Bright Uro has 3 listed competitors in our database, 1 of them funded. They include Stream DX, Clariflow and Spark Diagnostics.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
streamdx.com2014West Valley, United States10
Uro-flow meters for LUTS diagnosis and patient care are provided.
clariflow.com2014New York, United States$100,000
Provides DIY test kits for benign prostatic hyperplasia (BPH).
sparkdiagnostics.com2016San Francisco, United States
Offers instant diagnostic kits for health parameters using mobile apps.
Premium access

Detailed competitors of Bright Uro

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Bright Uro

The website of Bright Uro (brighturo.com) receives about 2.1K visits a month.

  • Monthly visits
    2.1K

    ▲ 57.5% vs previous month

Top companies in Genitourinary Disorders

3 companies that operate in the same segment as Bright Uro (Genitourinary Disorders) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutics for drug-resistant bacterial infections are developed.
2013Cambridge, Massachusetts, United StatesUSD 114.7 MUSD 59.62 M32
Sacral neuromodulation devices are developed for urinary and bowel control.
2013Irvine, California, United StatesUSD 143.47 M
Provider of surgical devices for vertical hernia repair and abdominal wall reconstruction
2012Malvern, Pennsylvania, United StatesUSD 104.6 MUSD 80.28 M209
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Bright Uro

Premium access

Complete news archive for Bright Uro

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bright Uro

Bright Uro was founded in 2021.

Bright Uro is headquartered in Aliso Viejo, United States. It is registered at Aliso Viejo, California, United States.

Derek Herrera is the CEO of Bright Uro, as recorded in our data. They have also founded this company.

Bright Uro is a funded company, having raised a total of $94.99M across 8 funding rounds to date. The company's 1st funding round was a Grant of $2.05M, raised on Sep 2021.

Bright Uro has 23 employees.

Bright Uro was founded in 2021 and is headquartered in Aliso Viejo, United States. Operations center on the medical device sector, specifically urology diagnostics. The Glean Urodynamics System is offered, which includes an insertion tool, a Bluetooth-enabled pressure sensor within a flexible silicone tube, a software application, and a uroflowmeter for measuring volume and flow rates. Focus remains on tools for lower urinary tract disease assessment.

Bright Uro's top competitors include Stream DX, Clariflow and Spark Diagnostics.

Bright Uro has 9 investors. Key investors include NIH, Laborie Medical, HHS, University of California, and Military Health.

Bright Uro operates through Bright Uro, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available